AstraZeneca Pharma India plans to sell its 64-acre production facility in North Bengaluru as part of a strategic review of its global manufacturing and supply network conducted by its parent company.The deal is expected to fetch over ‘3,200 crore. This move is a part of its broader corporate land monetisation plan.According to property consultants, a…
READ MORERepresentational image.Representational image.SynopsisIt might not have made the headlines, but real estate stocks have witnessed a correction. However, unlike in the past, when corrections used to be sharp and deep, this time it has been mostly sideways for a large number of stocks. Check out Stock Reports Plus, powered by Refinitiv, for price targets of…
READ MORESynopsisWhen valuations are as expensive as they are now, it is time to be selective. But being selective is a generic term. For instance, the parameters used to pick a stock from the pharma industry would be very different from the ones used to buy infrastructure or capital goods stocks. The different macro and micro…
READ MOREMUMBAI: The residential sales across India’s top seven cities are expected to witness double digit growth in 2024-25. The area sold in Mumbai Metropolitan Region (MMR), National Capital Region (NCR), Bengaluru, Hyderabad, Pune, Kolkata, Chennai is likely to increase 10-12% to 785-800 million sq ft in the current financial year, on a high base of…
READ MOREThe tier I residential real estate inventory stock of the top eight cities across India remains at comfortable level compared to historical levels and the quarter-to-sales ratio is at moderate levels of 11 compared to the past six years’ high of 13 in 2018-19, said India Ratings & Research (Ind-Ra).The ratings agency, based on the…
READ MORE